Expression of EspA in Lactococcus lactis NZ9000 and the detection of its immune effect in vivo and vitro

Immunopharmacology and Immunotoxicology

Volumn 32, Issue 1, 2010, Pages 133-140

  Luan, Jingjing ^a   Zhuang, Zhong ^b   Liu, Yan ^d   Yun, Kong ^a   Chen, Min ^a   Wang, Peng George ^a,c  

^a SHANDONG UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c OHIO STATE UNIVERSITY   (United States)

^d Shandong College of Animal and Veterinary   (China)

Author keywords

Antibody; Escherichia coli O157:H7; EspA protein; Immunity; Lactococcus lactis NZ9000

Indexed keywords

ACTIN; BACTERIAL PROTEIN; BACTERIAL VACCINE; ESCHERICHIA COLI SECRETED PROTEIN A; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTOCOCCUS LACTIS NZ9000; POLYCLONAL ANTISERUM; PSEC ESCHERICHIA COLI SECRETED PROTEIN A; PSEC LEISS ESCHERICHIA COLI SECRETED PROTEIN A; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BAGG ALBINO MOUSE; CONTROLLED STUDY; ESCHERICHIA COLI O157; FEMALE; HOST CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FEMALE; HELA CELLS; HUMANS; IMMUNIZATION; LACTOCOCCUS LACTIS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOCOCCUS LACTIS; MUS;

EID: 77249169790     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923970903207083     Document Type: Article

References (28)

1. Baldwin T.O.; Holzman T.F.; Holzman R.B. Active center-based immunoassay approach using bacterial luciferase. Methods Enzymol. 1986, 133, 248-264.
2. Bradford M.M. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
3. Elder R.O.; Keen J.E.; Siragusa G.R.; Barkocy-Gallagher G.A.; Koohmaraie M.; Laegreid W.W. Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides and carcasses of beef cattle during processing. Proc. Natl. Acad. Sci. 2000(7), 2999-3003.
4. Enouf V.; Langella P.; Commissaire J.; J. Cohen; Corthier G. Bovine Rotavirus Nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl. Environ. Microbiol. 2001, 67 (4), 1423-1428.
5. Frankel G.; Phillips A.D.; Rosenshine G.D.; Kaper J.B.; Knutton S. Enteropathogenic and enterohemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 1998, 30 (5), 911-921.
6. Heijne V.G. The signal peptide. J. Membr. Biol. 1990, 115 (3), 195-201.
7. Gabriela P.; Fuller R.; Raya R. Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2001, 2 (1), 27-42.
8. Glenting J.; Madsen S.M.; Vrang A.; Fomsgaard A.; Israelsen H. A plasmid selection system in Lactococcus lactis and its use for gene expression in Lactococcus lactis and human kidney fibroblasts. Appl. Environ. Microbiol. 2002, 68 (10), 5051-5056.
9. Grangette C.; Muller A. H.; Goudercourt D.; Geoffroy M.C.; Turneer M.; Mercenier A. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 2001, 69 (3): 1547-1553.
10. Karmali M.A. Laboratory diagnosis of verotoxin-producing Escherichia coli infections. Clin. Microbiol. 1987, 9 (9), 65-70.
11. Karmali M.A. Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 1989, 2 (1), 15-38.
12. Knutton S.; Rosenshine I.; Pallen M. J.; Nisan I.; Neves B. C.; Bain C.; Wolff C.; Dougan G.; Frankel G. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO 1998,17 (8), 2166-2176.
13. Langella P., and Le L.Y. Heterologous protein secretion in Lactococcus lactis: a novel antigen delivery system. Braz. J. Med. Biol. Res. 1999, 32 (2), 191-198.
14. Lee M.H.; Roussel Y.; Wilks M.; Tabaqchali S. Expression of helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 2001, 19 (28), 3927-3935., 97
15. Medaglini D.; Ciabattini A.; Spinosa M.R.; Maggi T.; Marcotte H.; Oggioni M.R.; Pozzi G. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. Vaccine 2001, 19 (15), 1931-1939.
16. Miettinen M.; Vuopio-Varkila J.; Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 1996, 64 (12), 5403-5405.
17. Norton P.M.; LePage R.W., and Wells J.M. Progress in the development of Lactococcus lactis as a recombinant mucosal vaccine delivery system. Folia Microbiol. 1995, 40 (3), 225-230.
18. Perna N.T.; Mayhew G.F.; Posfia G.; Elliot S.; Donnenberg M.S.; Kaper J.B.; Blattner F.R. Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7. Infect.Immun. 1998, 66 (8), 3810-3817.
19. Pugsley A.P. The complete general secretary pathway in gram-negative bacteria. Microbiol. Rev. 1993, 57 (1), 50-108.
20. Ruyter P.G.; Kuipers O.P., and Vos W.M. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 1996, 62 (10), 3662-3667.
21. Sarah J.D.; Kocsis E.; Morris E.; Knutton S.; Booy F.P.; Frankel G. 3D structure of EspA filaments from enteropathogenic Escherichia coli. Mol. Microbiol. 2003, 49 (2), 301-308.
22. Shaw R.K.; Daniell S.; Ebel F.; Frankel G.; Knutton S. EspA filamentmediated protein translocation into red blood cells. Cell microbiol. 2001, 3 (4), 213-222.
23. Scheppler L., Vogel M., Zuercher A.W., Zuercher M., Germond J.E., Miescher S.M., Stadler B.M.: Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 2002, 20 (23), 2913-2920.
24. Shu Q., and Gill H.S. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20™) against Escherichia coli O157:H7 infection in mice. FEMS Immun. Med. Microbiol. 2002, 34 (1), 59-64.
25. Wu C.Y.; Yang G.; Luis G.B.H.; Pang Q.F; Zeng Y.M.; Wang J.; Gao X.Y. Immunomodulatory effects of IL-12 secreted by Lactococcus lactis on Th1/Th2 balance in ovalbumin (OVA)-induced asthma model mice. Inter. immunophar. 2006, 6 (4), 610-615.
26. Wu S.C.; Ye R.; Wu X.C.; Ng S.C.; Wong S.L. Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones. J. Bacteriol. 1998, 180 (11), 2830-2835.
27. Wu X.C.; Lee W.; Tran L.; Wong S.L. Engineering a Bacillus subtilis expression-secretion system with a strain deficient in six extracellular proteases. J. Bacteriol. 1991, 173 (16), 4952-4958.
28. Zhuang Z., Wu Z.G., Chen M., and Wang P. G.: Secretion of human interferon- ? 1b by recombinant Lactococcus lactis. Biotech. lett. 2008, 30 (10), 1819-1823.